Yohimbine blocks a natural brake on adrenaline. Its strongest evidence supports modest help for erectile difficulty; its fat-loss reputation rests on thin, mixed data, and energy or longevity claims are speculative. It reliably raises heart rate and blood pressure and can trigger anxiety. Product quality varies widely, making real-world effects hard to predict. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Resting blood pressure | <120/80 mmHg | Yohimbine raises blood pressure; sets a safety baseline and stop threshold |
| Resting heart rate | 50–70 bpm | Yohimbine is a stimulant that can cause tachycardia |
| Fasting glucose | 70–90 mg/dL | Adrenergic stimulation can transiently raise glucose and blunt fat loss |
| eGFR | >90 mL/min/1.73m² | Reduced kidney clearance raises drug exposure and side-effect risk |
Cadence: Before and 1–2 h after dosing during the first 1–2 weeks; then weekly for the first month; then every 3–6 months if use continues; reassess after any dose increase or new stimulant.